Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | CASP2 | P42575 | 1/20 | 0.40 |
| ▸ | CASP6 | P55212 | 1/20 | 0.40 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 3/20 | 0.39 |
| ▸ | PPOX | P50336 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 4/20 | 0.34 |
| ▸ | MAOB | P27338 | 4/20 | 0.34 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
| ▸ | FER | P16591 | 1/20 | 0.33 |
| ▸ | LTK | P29376 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 4/20 | 0.32 |
| ▸ | EGFR | P00533 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4896875 | 0.70 | ACVR1 (0.61) | GSK3BMAOAMAOBPDGFRAFER | |
| SCHEMBL10926488 | 0.69 | MEN1 (0.39) | CASP7MAOAMAOBTDP1MAPT | |
| SCHEMBL9674007 | 0.67 | MEN1 (0.37) | MAOAMAOBTDP1MAPTMEN1 | |
| SCHEMBL3678137 | 0.67 | ESR1 (0.42) | ESR1ESR2 | |
| SCHEMBL13409576 | 0.65 | CASP3 (0.44) | GSK3BCASP7CASP3MAPTMEN1 | |
| SCHEMBL15488741 | 0.65 | GSK3B (0.50) | GSK3BCASP7CASP3CASP2CASP6 | |
| Phthalimide SCHEMBL64 | 0.65 | GSK3B (1.00) | GSK3BCASP7CASP3CASP2CASP6 | |
| Phthalimide SCHEMBL11040503 | 0.65 | GSK3B (1.00) | GSK3BCASP7CASP3CASP2CASP6 | |
| SCHEMBL239945 | 0.65 | GSK3B (0.50) | GSK3BCASP7CASP3CASP2CASP6 | |
| Phthalimide SCHEMBL7771670 | 0.65 | GSK3B (1.00) | GSK3BCASP7CASP3CASP2CASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12389734-B2 | Inverted polymer photovoltaic cell and method for preparation thereof | ENI S.P.A. (IT) | 2025-08-12 | — | — | US | claimed |
| US-12364155-B2 | Polymer compositions for vertical channel organic electrochemical transistors and complementary logic circuits | NORTHWESTERN UNIVERSITY (US) | 2025-07-15 | — | — | US | claimed |
| US-20250098393-A1 | MONOLITHIC INTEGRATION OF VERTICAL ELECTROCHEMICAL TRANSISTORS | NORTHWESTERN UNIVERSITY | 2025-03-20 | — | — | US | claimed |
| US-20250089430-A1 | ORGANIC SOLAR CELLS AND METHODS OF MAKING THE SAME | UNIV NEW YORK (US) | 2025-03-13 | — | — | US | claimed |
| US-20250051352-A1 | DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIOPHENE GROUPS | ENI S.P.A. (IT) | 2025-02-13 | — | — | US | claimed |
| US-12156413-B2 | Organic solar cells and methods of making the same | UNIV NEW YORK (US) | 2024-11-26 | — | — | US | claimed |
| US-20240343739-A1 | TWO DIMENSIONAL BENZO[4,5]IMIDAZO[2,1-A]ISOINDOLEINCORPORATED NON-FULLERENE ELECTRON ACCEPTORS FOR ORGANIC PHOTOVOLTAIC DEVICES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2024-10-17 | — | — | US | claimed |
| EP-4444723-A1 | DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIOPHENE GROUPS | ENI S.p.A. (IT) | 2024-10-16 | — | — | EP | claimed |
| CN-118284614-A | Diaryloxybenzobisoxazole compounds disubstituted with thienothiophene groups | 埃尼股份公司 | 2024-07-02 | — | — | CN | claimed |
| EP-3563436-B1 | HOLE TRANSPORTING MATERIAL AND PHOTOVOLTAIC DEVICE THAT USES IT | ENI SPA (IT) | 2024-06-26 | — | — | EP | claimed |
| CN-104448253-A | Aromatic alkyne copolymer based on benzo[1,2-b:4,5-b']dithiophene and preparation method thereof | UNIV SHANGHAI | 2015-03-25 | — | — | CN | claimed |
| US-20150060774-A1 | IMAGE SENSORS WITH ORGANIC PHOTODIODES AND METHODS FOR FORMING THE SAME | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2015-03-05 | — | — | US | claimed |
| US-20150060775-A1 | ORGANIC PHOTO DIODE WITH DUAL ELECTRON BLOCKING LAYERS | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2015-03-05 | — | — | US | claimed |
| US-20130334520-A1 | GERMOLE CONTAINING CONJUGATED MOLECULES AND POLYMERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-12-19 | — | — | US | claimed |
| EP-1964842-B1 | 5H-THIENO [3,4-c]PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR | TIAN JIN HEMAY BIO TECH CO LTD (CN) | 2012-09-12 | — | — | EP | claimed |
| WO-2012118728-A2 | GERMOLE CONTAINING CONJUGATED MOLECULES AND POLYMERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-09-07 | — | — | WO | claimed |
| US-20080176900-A1 | 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS | TIANJIN HEMAY BIO-TECH CO., LTD. (CN) | 2008-07-24 | — | — | US | claimed |
| EP-1042315-B1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE CO CHEM PHARM FAB (DE) | 2004-04-14 | — | — | EP | claimed |
| EP-1042315-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | claimed |
| WO-1999031087-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240343739-A1 | TWO DIMENSIONAL BENZO[4,5]IMIDAZO[2,1-A]ISOINDOLEINCORPORATED NON-FULLERENE ELECTRON ACCEPTORS FOR ORGANIC PHOTOVOLTAIC DEVICES | WASF2, OPRM1, VDAC2 | GSK3B 4444/4885CASP7 4091/4885CASP3 3788/4885 |
| US-20080176900-A1 | 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS | TNF, TNFRSF1A, CD40 | GSK3B 2996/4885CASP7 333/4885CASP3 1095/4885 |
| US-20250051352-A1 | DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIOPHENE GROUPS | SLC9A5, SLC7A5, SLC39A3 | GSK3B 3030/4885CASP7 3330/4885CASP3 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.